Complimentary journeys to the World Congress of Gastroenterology - An inquiry of potential sponsors and beneficiaries

Zeitschrift fur Gastroenterologie

Volumn 38, Issue 1, 2000, Pages 7-11

  Eckardt, Volker F ^a  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

Gifts to physicians; Medical conventions; Medical ethics; Pharmaceutical marketing; Pharmaceutical sponsoring

Indexed keywords

ARTICLE; CONTINUING EDUCATION; DRUG MARKETING; MEDICAL EDUCATION; MEDICAL ETHICS;

EMPIRICAL APPROACH; HEALTH CARE AND PUBLIC HEALTH;

ATTITUDE OF HEALTH PERSONNEL; CONFLICT OF INTEREST; CONGRESSES; CURRICULUM; DRUG INDUSTRY; EDUCATION, MEDICAL, CONTINUING; ETHICS, MEDICAL; FINANCIAL SUPPORT; GASTROENTEROLOGY; HUMANS; PHYSICIAN'S ROLE; TRAVEL;

EID: 0033964003     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-14845     Document Type: Article

References (14)

1. Bundesministerium für Bildung und Forschung: Bundesbericht Forschung 1996. Bonn, Bonner Universitätsdruckerei, 1996
2. Waud DR. Pharmaceutical promotions - A free lunch? N Engl J Med 1992; 327: 351-3
3. Orlowski JP, Wateska L. The effects of pharmaceutical firm enticements on physician prescribing patterns. There is no such thing as a free lunch. Chest 1992; 102: 270-3
4. Rawlings MD. Doctors and the drug makers. Lancet 1984; 2: 276-8
5. Goldfinger SE. A matter of influence. N Engl J Med 1987; 316: 1408-9
6. Opren Scandal. Lancet 1983; 1: 219-20
7. Jenike MA. Relations between physicians and pharmaceutical companies: Where to draw the line. New Engl J Med 1990; 322: 557
8. The relationship between physicians and the pharmaceutical industry. A report of the Royal College of Physicians. J R Coll of Physicians Lond 1986; 20: 235-42
9. American Collage of Physicians. Physicians and the pharmaceutical industry. Ann Intern Med 1990; 112: 624-6
10. Bundesärztekammer. Berufsordnung für die deutschen Ärzte. Dtsch Ärztebl 1996; 93: A 407-14
11. Gifts to physicians from industry. JAMA 1991; 265: 501
12. Chren MM, Landefeld CS. Physicians behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA 1994; 271: 684-9
13. Avron J, Chen M, Hartley H. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 1982; 73: 4-8
14. Bundeskartellamt: Bekanntmachung Nr. 11/96 über den Antrag des Verbandes Forschender Arzneimittelhersteller e. V. auf Anerkennung einer Wettbewerbsregel. Bundesanzeiger 1996; 52: 2786-9